References
- Cochran W.G., Cox G.M. Experimental Designs. Wiley, New York 1957
- Hall E.J., Aster M., Geard C., Biaglow J. Cytotoxicity of Ro 07-0582: Enhancement by hyperthermia and protection by cysteamine. British Journal of Cancer 1977; 35: 809–815
- Hewick D.S. Reductive metabolism of nitrogen-containing functional groups. Metabolic Basis of Detoxification, W.B. Jakoby, J.R. Bend, J. Caldwell. Academic Press, New York 1982; 151–170
- Honess D.J., Bleehen N.M. Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain. British Journal of Cancer 1982; 46: 236–248
- Honess D.J., Bleehen N.M. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only. British Journal of Radiology 1985; 58: 63–72
- Kallman R.F., Silini G., van Putten L.M. Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors. Journal of the National Cancer Institute 1967; 39: 539–549
- Kirk R.E. Experimental Designs. Brooks/Cole, Belmont, CA 1982; 592–592
- Lee F.Y.F., Workman P. Misonidazole and CCNU: Further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain. British Journal of Cancer 1984; 49: 579–585
- Li J.C.R. Design and statistical analysis of some confounded factorial experiments. Iowa Agricultural Experiment Station Research Bulletin 1944; 333: 449–492
- Milligan A.J. Whole-body hyperthermia induction techniques. Cancer Research (Suppl.) 1984; 44: 4869s–4872s
- Mulcahy R.T. Effect of oxygen on Misonidazole chemosensitization and cytotoxicity in vitro. Cancer Research 1984; 44: 4409–4413
- Olive P.L. Enhanced metabolic reduction and cytotoxicity of nitrofurazone at high temperatures. Cancer Biochemistry and Biophysics 1978; 2: 155–160
- Olive P.L. Mechanisms of the in vitro toxicity of nitroheterocycles including Flagyl and misonidazole. Radiation Sensitizers, Their Use In the Clinical Management of Cancer, L. Brady. Masson, New York 1980; 39–44
- Robins H.I., Dennis W.H., Neville A.J., Schecterle L.M., Martin P.A., Grossman J., Davis T.E., Neville S.R., Gillis W.K., Rusy B.F. A non-toxic system for 41·8°C whole-body hyperthermia: Results of a Phase I study using a radiant heat device. Cancer Research 1985; 45: 3937–3944
- Siemann D.W., Hill R.P., Bush R.S. The importance of pre-irradiation breathing times of oxygen and carbogen (5% CO:95% O) on the in vivo radiation response of a murine sarcoma. International Journal of Radiation Oncology, Biology and Physics 1977; 2: 903–909
- Siemann D.W. Response of murine tumors to combinations of CCNU with Misonidazole and other radiation sensitizers. British Journal of Cancer 1982; 45: 272–281
- Siemann D.W. Modification of chemotherapy by nitroimidazoles. International Journal of Radiation Oncology, Biology, Physics 1984; 10: 1585–1594
- Siemann D.W., Mulchay R.T. Sensitization of cancer chemotherpeutic agents by nitroheterocycles. Biochemical Pharmacology 1985; 35: 111–115
- Sridhar R., Sutherland R.M. Hyperthermic potentiation of Ro-07-0582 in multicell spheroids. International Journal of Radiation Oncology, Biology and Physics 1977; 2: 531–535
- Steinberg D.M., Hunter W.G. Experimental design: Review and comment. Technometrics 1984; 26: 71–130
- Stratford I.J., Adams G.E. The effect of hyperthermia on the differential cytotoxicity of a hypoxic cell radiosensitizer, the 2-nitroimidazole Ro-07-0582, on mammalian cells in vitro. British Journal of Cancer 1977; 35: 307–313
- Thomson J.E., Rauth A.M. An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions. Radiation Research 1974; 58: 262–276